Latest news
4D Molecular Therapeutics, Inc. (FDMT) insider sells 26,842 shares under plan - Stock TitanStock Titan · Wed, 05 Aug 2026 20:11:40 GMT4D Molecular Therapeutics (FDMT) CEO sells 12,415 shares via 10b5-1 plan - Stock TitanStock Titan · Tue, 04 Aug 2026 20:46:01 GMT4D Molecular Therapeutics CEO David Kirn disposes of 12,415 shares worth $124,987 - BitgetBitget · Tue, 04 Aug 2026 07:00:00 GMTFDMT (FDMT) investor David Kirn plans Rule 144 sale of 12,415 shares - Stock TitanStock Titan · Mon, 03 Aug 2026 21:30:55 GMT